about
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesStructural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationA short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodiesNew Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyCutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies.
P50
Q27644515-2CA30F7D-E5DF-4DDF-A297-63577871E52BQ27678312-47F224E9-DEB8-4C31-897D-7C07792022B6Q27684578-51969E3F-BBCC-4432-8089-895CDA07DAE5Q36171938-1F0B7D50-AE5D-4777-A672-6FE30BBED5A2Q36433894-A031AD79-0E8C-4918-AE93-EFB0533886A6Q39588420-AE74B21A-A4D3-426B-9042-F0256CDF76CCQ39966889-6D73CB15-3CC4-49C9-AC54-6A4A248D2B2EQ40248504-3A239B5A-9101-4149-9D56-C803CF05038FQ46988368-F00DC40A-87F8-4E42-B9B9-13C4DC257E59
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ryan P. Staupe
@ast
Ryan P. Staupe
@en
Ryan P. Staupe
@es
Ryan P. Staupe
@nl
Ryan P. Staupe
@sl
type
label
Ryan P. Staupe
@ast
Ryan P. Staupe
@en
Ryan P. Staupe
@es
Ryan P. Staupe
@nl
Ryan P. Staupe
@sl
prefLabel
Ryan P. Staupe
@ast
Ryan P. Staupe
@en
Ryan P. Staupe
@es
Ryan P. Staupe
@nl
Ryan P. Staupe
@sl
P106
P1153
55323422500
P31
P496
0000-0003-0793-524X